Cargando…
Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease
Each year, the incidence of nonalcoholic fatty liver (NAFLD) disease increases. NAFLD is a chronic disease. One of the most common causes of NAFLD is an inadequate lifestyle, which is characterized by a lack or low physical activity and eating highly processed foods rich in saturated fat and salt an...
Autores principales: | Jarmakiewicz-Czaja, Sara, Sokal, Aneta, Pardak, Piotr, Filip, Rafał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117063/ https://www.ncbi.nlm.nih.gov/pubmed/35600209 http://dx.doi.org/10.1155/2022/4344905 |
Ejemplares similares
-
What Was First, Obesity or Inflammatory Bowel Disease? What Does the Gut Microbiota Have to Do with It?
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2020) -
Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2022) -
TiO(2) – do we have to worry about it? One of the important aetiological factors in inflammatory bowel disease
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2021) -
What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2023) -
The Role of Genetic and Epigenetic Regulation in Intestinal Fibrosis in Inflammatory Bowel Disease: A Descending Process or a Programmed Consequence?
por: Jarmakiewicz-Czaja, Sara, et al.
Publicado: (2023)